The Framingham facility alleges that labs who manipulate cannabis safety testing are enriching themselves at their expense.

Sanofi has made an interesting choice for its new head of R&D, turning to Houman Ashrafian, who has deep expertise in the biopharma industry, but can also draw on his most recent role as managing ...